Leukemia Clinical Trials in Austin

Showing 1021-1040 of 1,100 trials

Study of Postoperative Analgesia in Bunionectomy

NCT00890682

After undergoing bunion surgery, patients are given a pain medicine injection that may last for up to several days or a placebo. Their pain and pain medicine use is then monitored.

BunionHallux Valgus

Pacira Pharmaceuticals, Inc193 participantsStarted Apr 2009

Austin, Texas, United States

COMPLETEDPhase 2< 1 mile

A Study of Sativex® for Pain Relief in Patients With Advanced Malignancy.

NCT00530764

The purpose of this study is to determine the effective dose range and to demonstrate a non-effective dose range of Sativex in patients with advanced cancer, who experience inadequate pain relief even though they are on optimized chronic opioid therapy.

Palliative CarePainCancer

GW Pharmaceuticals Ltd360 participantsStarted Nov 2007

Tuscaloosa, Alabama, United States • Casa Grande, Arizona, United States • Fountain Valley, California, United States +107 more locations

Study of Postoperative Analgesia in Bunionectomy

A Study of Sativex® for Pain Relief in Patients With Advanced Malignancy.

Leukemia Trials in Other Cities

Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia

Interleukin-2 in Treating Children Who Have Undergone Bone Marrow Transplantation for Acute Myeloid Leukemia

A Study of Mapatumumab in Combination With Paclitaxel and Carboplatin in Subjects With Non-small Cell Lung Cancer

Centralized Cord Blood Registry to Facilitate Unrelated Cord Blood Transplantation

Radiation Therapy and Chemotherapy in Treating Children With CNS Relapse From Acute Lymphoblastic Leukemia

Topotecan in Treating Children With Refractory Leukemia

Combination Chemotherapy in Treating Children With Acute Lymphocytic Leukemia

Study of Obatoclax in Previously Untreated Acute Myeloid Leukemia (AML)

Extensive Small Cell Lung Cancer Treatment Using An Investigational Drug Plus Chemotherapy In Chemotherapy-Naive Adults

Study of TRM-1(TRAIL-R1 Monoclonal Antibody) in Subjects With Relapsed or Refractory Non-Small Cell Lung Cancer (NSCLC)

Study of the Safety and Tolerability of PCI-32765 in Patients With Recurrent B Cell Lymphoma

Safety Study of XL147 (SAR245408), in Combination With Paclitaxel and Carboplatin in Adults With Solid Tumors

A Randomized Phase 2 Study of Erlotinib + ARQ 197 Versus Erlotinib + Placebo in Previously Treated Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

A Phase 1/2 Study Evaluating ABT-751 in Combination With Alimta in Advanced Non-Small Cell Lung Cancer

Irinotecan in Treating Patients With Solid Tumors or Lymphoma Who Have Abnormal Liver or Kidney Function or Who Have Received Radiation Therapy to the Pelvis

Combination Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia

First Line Study of Tamibarotene in Combination for Advanced Non-Small Cell Lung Cancer

Alvocidib in Patients With Previously Treated Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia Arising From Chronic Lymphocytic Leukemia (CLL)

Other Conditions in Austin